• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    1/15/25 4:15:18 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email
    false 0001860543 0001860543 2025-01-13 2025-01-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    United States

    Securities and Exchange Commission

    Washington, D.C. 20549

     

    Form 8-K

    Current Report 

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): January 13, 2025

     

    CADRE HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware 001-40698 38-3873146
    (State or other jurisdiction (Commission File Number) (IRS Employer
    of incorporation)   Identification Number)

     

    13386 International Pkwy  
    Jacksonville, Florida 32218
    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (904) 741-5400

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol Name of each exchange on which
    registered
    Common Stock, par value $.0001 CDRE New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

      x Emerging growth company

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

     

    Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    (a) On January 13, 2025, Mr. Nicholas Sokolow notified the Board of Directors (the “Board”) of Cadre Holdings, Inc. (the “Company”) of his resignation as a director of the Company, as well as from all committees of the Board on which he currently serves and as lead independent director of the Board, effective as of January 31, 2025. Mr. Sokolow’s resignation was not the result of any dispute or disagreement with the Company on any matter relating to the operations, policies, or practices of the Company.

     

    (d)          The Company’s Board appointed Mr. Gianmaria Delzanno to serve on the Company’s Board effective as of January 13, 2025, until the Company’s next Annual Meeting of Stockholders and until his successor is duly elected and qualified. Following the effective date of Mr. Sokolow’s departure from the Board on January 31, 2025, Mr. Delzanno will replace Mr. Sokolow as the Board’s lead independent director and will also serve as chairman of the Board’s Nominating and Corporate Governance Committee as well as a member of the Board’s Audit Committee and Compensation Committee. In connection with the appointment of Mr. Delzanno to the Board, the current number of directors on the Board has been expanded and fixed from five directors to six directors.

     

    Mr.  Delzanno, 68 years old, is a veteran finance executive with over 40 years of experience in domestic and international M&A, corporate financing, debt and equity offerings and private equity. Since September 1996, Mr. Delzanno has served as the President of Delzanno & Co. Inc., a firm that he founded, advising domestic and international publicly traded and privately held companies in mergers and acquisitions, as well as providing corporate finance, restructuring, and general advisory and valuation services. From February 1984 to June 1996, Mr. Delzanno worked for the investment bank Schroder Wertheim & Co. Incorporated where he was a director in its Industrial Manufacturing Group, and led transactions including IPOs, M&A, private placements, and debt offerings.

     

    Mr. Delzanno also has decades of board of directors’ experience across various industries, with roles as chairman, board member, audit and compensation committee member, including serving from October 2015 to December 2021, on the board of directors of Tempel Steel Company, a family-owned manufacturer of components for electric motors and transformers with operations in the US, Canada, Mexico, China and India.

     

    Mr. Delzanno holds an M.B.A. from Columbia Business School and graduated with a B.S. in Applied Mathematics and Economics from Brown University.

     

    Based upon Mr. Delzanno’s extensive financial expertise, board of directors service across many industries as well as his experience in domestic and international M&A, corporate financing, debt and equity offerings and private equity, the Company believes that Mr. Delzanno has the requisite set of skills to serve as a Board or Board committee member of the Company. The Board has evaluated Mr. Delzanno’s independence from the Company based on the definition of “independence” established by the New York Stock Exchange and has determined that Mr. Delzanno qualifies as an independent director.

     

    Mr. Delzanno’s will receive compensation as a non-employee director in accordance with the Company’s director compensation program described in the Company’s proxy statement filed with the Securities and Exchange Commission on April 29, 2024.

     

     

     

     

    Item 9.01. Financial Statements and Exhibits

     

    (d) Exhibits.

     

    Exhibit

    Description

       
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: January 15, 2025

     

     CADRE HOLDINGS, INC.
      
     By: /s/ Blaine Browers
     Name: Blaine Browers
     Title: Chief Financial Officer

     

     

     

    Get the next $CDRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    More analyst ratings

    $CDRE
    SEC Filings

    View All

    SEC Form S-4 filed by Cadre Holdings Inc.

    S-4 - Cadre Holdings, Inc. (0001860543) (Filer)

    3/30/26 5:58:39 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 144 filed by Cadre Holdings Inc.

    144 - Cadre Holdings, Inc. (0001860543) (Subject)

    3/20/26 6:03:52 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 10-K filed by Cadre Holdings Inc.

    10-K - Cadre Holdings, Inc. (0001860543) (Filer)

    3/10/26 4:19:19 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadre Holdings to Acquire Assets of Tedder Industries, Including Alien Gear Holsters

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that it has agreed to acquire Alien Gear Holsters and certain assets from Tedder Industries, LLC, for $10.3 million through a court-supervised bankruptcy auction. Cadre President Brad Williams commented, "This transaction represents a compelling opportunity to acquire a recognized holster brand with an established direct-to-consumer presence. Alien Gear brings an experienced team with a customer-first mindset, and we are excited about the attr

    3/26/26 10:24:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports Fourth Quarter and Full Year 2025 Financial Results

    Generated Annual Net Sales of $610.3 Million, Gross Margin of 42.5% and Net Income of $44.1 Million Achieved Record Annual Adjusted EBITDA for Third Consecutive Year Expects Full Year 2026 Net Sales of $736 to $758 Million and Adjusted EBITDA of $136 to $141 Million, Reflecting Year-Over-Year Growth of 22% and 24%, Respectively, at Midpoints Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2025. Net sales of $1

    3/10/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Subsidiary Is Awarded $86 Million in Contracts by General Dynamics European Land Systems

    Company will Provide Life-Saving Blast Attenuation Seats in Support of Military Vehicle Crew Survivability Programs Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company") announced today that its subsidiary Med-Eng, LLC has been awarded two contracts with values of $74.6 million and $11.8 million by General Dynamics European Land Systems (GDELS) to provide blast attenuation seats. Delivering best-in-class protection, the seats will be deployed in the upcoming production of Mowag EAGLE V 4x4 command and control vehicles, and the Mowag EAGLE V 6x6 medium protected ambulance military vehicles. Cadre President Brad Williams commented, "These contracts represent another major win for Ca

    3/10/26 7:43:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Williams Brad

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    4/1/26 4:16:12 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Kanders Warren B

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    4/1/26 4:15:40 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Browers Blaine

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    4/1/26 4:15:27 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Financials

    Live finance-specific insights

    View All

    Cadre Holdings Reports Fourth Quarter and Full Year 2025 Financial Results

    Generated Annual Net Sales of $610.3 Million, Gross Margin of 42.5% and Net Income of $44.1 Million Achieved Record Annual Adjusted EBITDA for Third Consecutive Year Expects Full Year 2026 Net Sales of $736 to $758 Million and Adjusted EBITDA of $136 to $141 Million, Reflecting Year-Over-Year Growth of 22% and 24%, Respectively, at Midpoints Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2025. Net sales of $1

    3/10/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Announce Fourth Quarter and Full Year 2025 Earnings and 2026 Financial Guidance on March 10, 2026

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the fourth quarter that ended on December 31, 2025, on Tuesday, March 10, 2026, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, March 11, 2026, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To par

    2/24/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.10 Per Share; ~5% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 2 cents, or approximately 5%, over the previous annualized dividend of $0.38 per share. Cadre's dividend payment will be m

    1/20/26 4:42:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care